Home » Lonza Says U.S. Suit Won’t Stop Arch Chemicals Deal
Lonza Says U.S. Suit Won’t Stop Arch Chemicals Deal
Lonza said its acquisition of U.S. biocides maker Arch Chemicals would proceed as planned despite a U.S. investigation into three Swiss investment firms linked to alleged insider trading ahead of the $1.2 billion deal.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May